Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function (Stem Cells (2010) 28, (140) DOI:10.1002/stem.259);Mesenchymal cells appearing in pancreatic tissue culture are bone marrow-derived stem cells with the capacity to improve transplanted islet function

Stem Cells

Volumn 28, Issue 1, 2010, Pages 140-151

  Sordi, Valeria ^a   Melzi, Raffaella ^a   Mercalli, Alessia ^a   Formicola, Roberta ^a   Doglioni, Claudio ^b   Tiboni, Francesca ^c   Ferrari, Giuliana ^b,c   Nano, Rita ^a   Chwalek, Karolina ^d   Lammert, Eckhard ^d,e   Bonifacio, Ezio ^f   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^d MAX PLANCK INSTITUTE OF MOLECULAR CELL BIOLOGY AND GENETICS   (Germany)

^e HEINRICH HEINE UNIVERSITY   (Germany)

^f CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Islet function; Mesenchymal cells; Pancreatic tissue

Indexed keywords

CD45 ANTIGEN; GREEN FLUORESCENT PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; TISSUE CULTURE; TISSUE REPAIR;

MUS;

EID: 75349108811     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.314     Document Type: Erratum

References (54)

1. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418: 41-49.
2. Krause DS, Theise ND, Collector MI et al. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell 2001; 105:369-377.
3. Moriscot C, de Fraipont F, Richard MJ et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem Cells 2005;23: 594-603.
4. Timper K, Seboek D, Eberhardt M et al. Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochem Biophys Res Commun 2006;341:1135-1140.
5. Denner L, Bodenburg Y, Zhao JG et al. Directed engineering of umbilical cord blood stem cells to produce C-peptide and insulin. Cell Prolif 2007;40:367-380.
6. Karnieli O, Izhar-Prato Y, Bulvik S et al. Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 2007;25:2837-2844.
7. Gao F, Wu DQ, Hu YH et al. In vitro cultivation of islet-like cell clusters from human umbilical cord blood-derived mesenchymal stem cells. Transl Res 2008;151:293-302.
8. Ianus A, Holz GG, Theise ND et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 2003;111:843-850.
9. Lechner A, Yang YG, Blacken RA et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta-cells in vivo. Diabetes 2004;53:616-623.
10. Hess D, Li L, Martin M et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003;21:763-770.
11. Urbán VS, Kiss J, Kovacs J et al. Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 2008;26: 244-253.
12. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006;98:1076-1084.
13. Solari MG, Srinivasan S, Boumaza I et al. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes longterm islet allograft survival and sustained normoglycemia. J Autoimmun 2009;32:116-124.
14. Lee RH, Seo MJ, Reger RL et al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 2006;103:17438-17443.
15. Estrada EJ, Valacchi F, Nicora E et al. Combined treatment of intrapancreatic autologous bone marrow stem cells and hyperbaric oxygen in type 2 diabetes mellitus. Cell Transplant 2008;17:1295-1304.
16. Ouziel-Yahalom L, Zalzman M, Anker-Kitai L et al. Expansion and redifferentiation of adult human pancreatic islet cells. Biochem Biophys Res Commun 2006;341:291-298.
17. Lechner A, Nolan AL, Blacken RA et al. Redifferentiation of insulinsecreting cells after in vitro expansion of adult human pancreatic islet tissue. Biochem Biophys Res Commun 2005;327:581-588.
18. Gershengorn MC, Hardikar AA, Wei C et al. Epithelial-to-mesenchymal transition generates proliferative human islet precursor cells. Science 2004;306:2261-2264.
19. Eberhardt M, Salmon P, von Mach MA et al. Multipotential nestin and Isl-1 positive mesenchymal stem cells isolated from human pancreatic islets. Biochem Biophys Res Commun 2006;345:1167-1176.
20. Seeberger KL, Dufour JM, Shapiro AM et al. Expansion of mesenchymal stem cells from human pancreatic ductal epithelium. Lab Invest 2006;86:141-153.
21. Sordi V, Malosio ML, Marchesi F et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005;106:419-427.
22. Gallo R, Gambelli F, Gava B et al. Generation and expansion of multipotent mesenchymal progenitor cells from cultured human pancreatic islets. Cell Death Differ 2007;14:1860-1871.
23. Linning KD, Tai MH, Madhukar BV et al. Redox-mediated enrichment of self-renewing adult human pancreatic cells that possess endocrine differentiation potential. Pancreas 2004;29:e64-76.
24. Russ HA, Bar Y, Ravassard P et al. In vitro proliferation of cells derived from adult human beta-cells revealed by cell-lineage tracing. Diabetes 2008;57:1575-1583.
25. Chase LG, Ulloa-Montoya F, Kidder BL et al. Islet-derived fibroblastlike cells are not derived via epithelial-mesenchymal transition from Pdx-1 or insulin-positive cells. Diabetes 2007;56:3-7.
26. Atouf F, Park CH, Pechhold K et al. No evidence for mouse pancreatic beta-cell epithelial-mesenchymal transition in vitro. Diabetes 2007;56:699-702.
27. Morton RA, Geras-Raaka E, Wilson LM et al. Endocrine precursor cells from mouse islets are not generated by epithelial-to-mesenchymal transition of mature beta cells. Mol Cell Endocrinol 2007;270: 87-93.
28. Weinberg N, Ouziel-Yahalom L, Knoller S et al. Lineage tracing evidence for in vitro dedifferentiation but rare proliferation of mouse pancreatic beta-cells. Diabetes 2007;56:1299-1304.
29. Piemonti L, Leone BE, Nano R et al. Human pancreatic islets produce and secrete MCP-1/CCL2: Relevance in human islet transplantation. Diabetes 2002;51:55-65.
30. Hotz HG, Reber HA, Hotz B et al. An orthotopic nude mouse model for evaluating pathophysiology and therapy of pancreatic cancer. Pancreas 2003;26:E89-98.
31. Melzi R, Sanvito F, Mercalli A et al. Intrahepatic islet transplant in the mouse: Functional and morphological characterization. Cell Transplant 2008;17:1361-1370.
32. Piemonti L, Bertuzzi F, Nano R et al. Effects of cryopreservation on in vitro and in vivo long-term function of human islets. Transplantation 1999;68:655-662.
33. Minasi MG, Riminucci M, De Angelis L et al. The meso-angioblast: A multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues. Development 2002; 129:2773-2783.
34. Lardon J, Corbeil D, Huttner WB et al. Stem cell marker prominin-1/ AC133 is expressed in duct cells of the adult human pancreas. Pancreas 2008;36:e1-6.
35. Deschaseaux F, Gindraux F, Saadi R et al. Direct selection of human bone marrow mesenchymal stem cells using an anti-CD49a antibody reveals their CD45med, low phenotype. Br J Haematol 2003;122: 506-517.
36. Kaufman DB, Gores PF, Field MJ et al. Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 1994;43:778-783.
37. Zhang YC, Molano RD, Pileggi A et al. Adeno-associated virus transduction of islets with interleukin-4 results in impaired metabolic function in syngeneic marginal islet mass transplantation. Transplantation 2002;74:1184-1186.
38. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society For Cellular Therapy Position Statement. Cytotherapy 2006;8:315-317.
39. Kaiser S, Hackanson B, Follo M et al. BM cells giving rise to MSC in culture have a heterogeneous CD34 and CD45 phenotype. Cytotherapy 2007;9:439-450.
40. Koide Y, Morikawa S, Mabuchi Y et al. Two distinct stem cell lineages in murine bone marrow. Stem Cells 2007;25:1213-1221.
41. Rogers I, Yamanaka N, Bielecki R et al. Identification and analysis of in vitro cultured CD45-positive cells capable of multi-lineage differentiation. Exp Cell Res 2007;313:1839-1852.
42. Ooi YY, Ramasamy RVidyadaran S. Mouse bone marrow mesenchymal stem cells acquire CD45-CD106+ immunophenotype only at later passages. Med J Malaysia 2008;63 Suppl A:65-66.
43. Ogawa M, LaRue ACDrake CJ. Hematopoietic origin of fibroblasts/ myofibroblasts: Its pathophysiologic implications. Blood 2006;108: 2893-2896.
44. Chen LB, Jiang XB, Yang L. Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 2004;10:3016-3020.
45. Sun J, Yang Y, Wang X et al. Expression of Pdx-1 in bone marrow mesenchymal stem cells promotes differentiation of islet-like cells in vitro. Sci China C Life SCI 2006;49:480-489.
46. Battula VL, Bareiss PM, Treml S et al. Human placenta and bone marrow derived MSC cultured in serum-free, b-FGF-containing medium express cell surface frizzled-9 and SSEA-4 and give rise to multilineage differentiation. Differentiation 2007;75:279-291.
47. Woodbury D, Reynolds K, Black IB. Adult bone marrow stromal stem cells express germline, ectodermal, endodermal, and mesodermal genes prior to neurogenesis. J Neurosci Res 2002;69:908-917.
48. Davani B, Ikonomou L, Raaka BM et al. Human islet-derived precursor cells are mesenchymal stromal cells that differentiate and mature to hormone-expressing cells in vivo. Stem Cells 2007;25: 3215-3222.
49. Kayali AG, Flores LE, Lopez AD et al. Limited capacity of human adult islets expanded in vitro to redifferentiate into insulin-producing beta-cells. Diabetes 2007;56:703-708.
50. Wu GD, Nolta JA, Jin YS et al. Migration of mesenchymal stem cells to heart allografts during chronic rejection. Transplantation 2003;75: 679-685.
51. Iso Y, Spees JL, Serrano C et al. Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment. Biochem Biophys Res Commun 2007;354:700-706.
52. Crisan M, Yap S, Casteilla L et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 2008;3: 301-313.
53. Au P, Tam J, Fukumura D et al. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008;111:4551-4558.
54. Johansson U, Rasmusson I, Niclou SP et al. Formation of composite endothelial cell-mesenchymal stem cell islets: A novel approach to promote islet revascularization. Diabetes 2008;57:2393-2401.